Frataxin mRNA isoforms in FRDA patients and normal subjects: Effect of tocotrienol supplementation

Provvidenza Maria Abruzzo, Marina Marini, Alessandra Bolotta, Gemma Malisardi, Stefano Manfredini, Alessandro Ghezzo, Antonella Pini, Gianluca Tasco, Rita Casadio

Research output: Contribution to journalArticle

Abstract

Friedreich's ataxia (FRDA) is caused by deficient expression of the mitochondrial protein frataxin involved in the formation of iron-sulphur complexes and by consequent oxidative stress. We analysed low-dose tocotrienol supplementation effects on the expression of the three splice variant isoforms (FXN-1, FXN-2, and FXN-3) in mononuclear blood cells of FRDA patients and healthy subjects. In FRDA patients, tocotrienol leads to a specific and significant increase of FXN-3 expression while not affecting FXN-1 and FXN-2 expression. Since no structural and functional details were available for FNX-2 and FXN-3, 3D models were built. FXN-1, the canonical isoform, was then docked on the human iron-sulphur complex, and functional interactions were computed; when FXN-1 was replaced by FXN-2 or FNX-3, we found that the interactions were maintained, thus suggesting a possible biological role for both isoforms in human cells. Finally, in order to evaluate whether tocotrienol enhancement of FXN-3 was mediated by an increase in peroxisome proliferator-activated receptor-γ (PPARG), PPARG expression was evaluated. At a low dose of tocotrienol, the increase of FXN-3 expression appeared to be independent of PPARG expression. Our data show that it is possible to modulate the mRNA expression of the minor frataxin isoforms and that they may have a functional role.

Original languageEnglish
Article number276808
JournalBioMed Research International
Volume2013
DOIs
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Frataxin mRNA isoforms in FRDA patients and normal subjects: Effect of tocotrienol supplementation'. Together they form a unique fingerprint.

  • Cite this

    Abruzzo, P. M., Marini, M., Bolotta, A., Malisardi, G., Manfredini, S., Ghezzo, A., Pini, A., Tasco, G., & Casadio, R. (2013). Frataxin mRNA isoforms in FRDA patients and normal subjects: Effect of tocotrienol supplementation. BioMed Research International, 2013, [276808]. https://doi.org/10.1155/2013/276808